When the price of a high-quality stock such as AbbVie (NYSE: ABBV) declines after a report revealing growth, outperformance, and better-than-expected guidance, it's almost always a good time to buy.
The only question is how far the stock price may pull back, and in this case, it likely won't be far. This stock is well-supported by market trends, including institutional and analyst coverage that point to accumulation and a steady price uptrend.
